| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.3B | $0.3B | $0.3B | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.92 | $0.70 | $0.59 | $0.74 | $0.56 | $0.71 | $0.62 | $0.62 |
| EPS (Diluted) | $0.91 | $0.69 | $0.59 | $0.74 | $0.56 | $0.71 | $0.62 | $0.62 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.7B | $30.0B | $29.9B | $29.5B | $29.3B | $26.2B | $19.7B | $19.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $28.2B | $25.0B | $25.2B | $25.0B | $24.6B | $21.9B | $16.3B | $16.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.5B | $5.0B | $4.8B | $4.5B | $4.7B | $4.3B | $3.4B | $3.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.4B | $0.8B | $0.6B | $0.1B | $0.1B | $0.3B |
| Investing Cash Flow | $-0.9B | $0.6B | $0.0B | $-3.4B | $0.0B | $0.1B | $-0.4B | $-0.9B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.7B | $-0.3B | $-0.1B | $0.1B | $0.9B | $1.1B | $0.0B | $-0.1B |